Sublingual immunotherapy in children: More optimism today: Letter to the Editor

Pediatric Allergy and Immunology

Volumn 20, Issue 4, 2009, Pages 399-400

  Larenas Linnemann, Désirée ^a  

^a Hospital Medica Sur   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE; POLLEN ANTIGEN;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; CHILD CARE; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG DOSE REGIMEN; HUMAN; IMMUNOTHERAPY; LETTER; PATIENT SELECTION; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; SENSITIZATION; TREATMENT DURATION;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; CHILD; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; HUMANS; RHINITIS, ALLERGIC, PERENNIAL;

EID: 66249136014     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2008.00809.x     Document Type: Letter

References (10)

1. Cox LS, Linnemann DL, Nolte H, et al. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006 : 117 : 1021 35.
2. Larenas-Linnemann D. Sublingual immunotherapy in children: how much proof of efficacy and safety do we have? Curr Allergy Asthma Rep 2008. Accepted for publication.
3. Roder E, Berger MY, de Groot H, et al. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review. Pediatr Allergy Immunol 2008 : 19 : 197 207.
4. Durham SR, Yang WH, Pedersen MR, et al. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006 : 117 : 802 9.
5. Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007 : 120 : 1338 45.
6. Valovirta E, Jacobsen L, Ljorring C, et al. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006 : 61 : 1177 83.
7. Brimnes J, Rask C, Urioste S, Lund K. Shorter dosing intervals of sublingual immunotherapy lead to more efficacious treatment in a mouse model of rhinitis. J Allergy Clin Immunol 2008 : 121 : S263.
8. Calderon MA, Birk AO, Andersen JS, et al. Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy. Allergy 2007 : 62 : 958 61.
9. Bufe A, Eberle P, Franke-Beckmann E, et al. Phase III trial with grass allergen tablet for sublingual immunotherapy in children. J Allergy Clin Immunol 2008 : 121 : S127.
10. Wahn UM, Melac M, Le Gall M. Efficacy and safety of 5 grass pollen sublingual tablets in children and adolescents with grass pollen rhinoconjunctivitis. Allergy 2008 : 63 : S45.